BioNassim joined Morgenthaler Ventures as Entrepreneur-in-Residence in 2005 and is now a Venture Partner. He is currently CEO and a member of the Board of Directors at Catalyst Biosciences. Prior to joining Morgenthaler in 2005, he was Senior Vice President and Chief Operating Officer at Sirna Therapeutics Inc. (Nasdaq:RNAI – acquired by Merck NYSE:MRK). He also held various R&D positions at both Sirna and Ribozyme Ph ....
Education